Pharmacological Properties of Tapinarof in Mice as a Novel Topical Agent for Plaque Psoriasis-Reference-Cited by-同舟云学术

Pharmacological Properties of Tapinarof in Mice as a Novel Topical Agent for Plaque Psoriasis

Published:2024 Issue:4 Volume:7 Page:116-122
ISSN:2434-432X
Container-title:BPB Reports
language:en
Short-container-title:

Author:

Urashima Toshiki¹,Katsuda Yoshiaki¹,Yoshiuchi Hiromi¹,Ebihara Shin¹,Shinozaki Yuichi¹,Kato Tomoko¹,Shimazaki Taishi²,Yasui Yuzo²,Mera Yasuko¹,Konishi Noriko¹

Affiliation:

1. Biological/Pharmacological Research Laboratories, Takatsuki Research Center, Central Pharmaceutical Research Institute, Japan Tobacco Inc.

2. Toxicology Research Laboratories, Yokohama Research Center, Central Pharmaceutical Research Institute, Japan Tobacco Inc.

Publisher

Pharmaceutical Society of Japan

Link

https://www.jstage.jst.go.jp/article/bpbreports/7/4/7_116/_pdf

Reference22 articles.

1. 1) Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA, 323, 1945–1960 (2020).

2. 2) Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J. Allergy Clin. Immunol., 140, 645–653 (2017).

3. 3) Hawkes JE, Yan BY, Chan TC, Krueger JG. Discovery of the IL-23/IL-17 signaling pathway and the treatment of psoriasis. J. Immunol., 201, 1605–1613 (2018).

4. 4) Cheung KL, Jarrett R, Subramaniam S, Salimi M, Gutowska-Owsiak D, Chen YL, Hardman C, Xue L, Cerundolo V, Ogg G. Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a. J. Exp. Med., 213, 2399–2412 (2016).

5. 5) Arakawa A, Siewert K, Stöhr J, Besgen P, Kim SM, Rühl G, Nickel J, Vollmer S, Thomas P, Krebs S, Pinkert S, Spannagl M, Held K, Kammerbauer C, Besch R, Dornmair K, Prinz JC. Melanocyte antigen triggers autoimmunity in human psoriasis. J. Exp. Med., 212, 2203–2212 (2015).